| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/06/1998 | EP0839191A1 Autoreactive peptides from human glutamic acid-decarboxylase (gad) |
| 05/06/1998 | EP0711355A4 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 05/06/1998 | EP0433299B1 Treatment of gastro-intestinal disorders |
| 05/06/1998 | CN1181021A Method and compositions for regulation of CD28 expression |
| 05/06/1998 | CN1181018A 多功能酶 Multifunctional enzyme |
| 05/06/1998 | CN1181017A Bioactive concentrate, its producing method and certain drug compositions containing also chondroitin sulphate |
| 05/06/1998 | CN1180745A New carrier for gene treatment |
| 05/06/1998 | CN1180739A Health-care wine and preparation method thereof |
| 05/06/1998 | CN1180709A Neopolynucleotide and polypeptide gene of genetic multiple exogenetic bone wart family |
| 05/06/1998 | CN1180544A Fumigant for reinforcing body primordial energy |
| 05/06/1998 | CN1180541A 珍芪降糖胶囊及其生产工艺 Zhen Qi Hypoglycemic Capsules and its production process |
| 05/06/1998 | CN1180532A Chinese drugs for darkening hair and its preparation method |
| 05/06/1998 | CN1180531A Chinese drugs soft extract used to activate blood flow and its preparation method |
| 05/06/1998 | CN1180525A Water soluble pearl powder and its processing technique |
| 05/06/1998 | CN1180519A Cosmetic composition containing neuropeptide Y receptor antagonist |
| 05/06/1998 | CA2220659A1 Microflora |
| 05/05/1998 | US5747653 Vaccination against infection caused by neisseria and purified with protein antigens complexes |
| 05/05/1998 | US5747645 Cytoplasmic antiproteinase-2 and cytoplasmic antiproteinase-3 and coding sequences |
| 05/05/1998 | US5747533 Use of ω-3-fatty acids |
| 05/05/1998 | US5747475 Chitosan-derived biomaterials |
| 05/05/1998 | US5747469 Methods and compositions comprising DNA damaging agents and p53 |
| 05/05/1998 | US5747444 Anticarcinogenic agents and interleukin-1 |
| 05/05/1998 | US5747325 Artificial cells for treatment of diabetes to form insulin |
| 05/05/1998 | US5747319 Human mRNA editing enzyme |
| 05/05/1998 | US5747318 Mitogen activated c-Fos regulating kinase, FRK |
| 05/05/1998 | US5747315 DNA encoding aspartyl tRNA synthetase from Streptococcus pneumoniae |
| 05/05/1998 | US5747313 DNA encoding histidyl tRNA synthetase from Streptococcus pneumoniae |
| 05/05/1998 | US5747307 Mason-Pfizer Monkey Retroviral packaging defective vectors |
| 05/05/1998 | US5747286 Polynucleotides encoding a transcriptional response regulator of Streptococcus pneumoniae |
| 05/05/1998 | US5747267 Method for identifying a G protein coupled glutamate receptor agonist and antagonist |
| 05/05/1998 | US5747071 Blood replacements |
| 05/05/1998 | US5747050 Peat-derived bioactive products, pharmaceutical and cosmetic compositions containing said products and processes for producing said products and compositions |
| 05/05/1998 | US5747043 Cucumis melo protein extract with antioxidant activity and process for preparing it, cosmetic composition or food composition containing such an extract |
| 05/05/1998 | US5747037 Monoclonal antibodies bound to epitopes secreted by hybridomas |
| 05/05/1998 | US5746979 Method for receiving and separating a fluid into its ingredients |
| 05/05/1998 | US5746223 Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis |
| 04/30/1998 | WO1998018005A1 Use of anti-embryonic hemoglobin antibodies to identify fetal cells |
| 04/30/1998 | WO1998017817A1 Retroviral vectors |
| 04/30/1998 | WO1998017816A1 Lentiviral vectors |
| 04/30/1998 | WO1998017806A1 Mini-e1a genes and gene products |
| 04/30/1998 | WO1998017791A1 Production of cartilage tissue using cells isolated from wharton's jelly |
| 04/30/1998 | WO1998017784A1 Method for in vitro preconditioning of myoblasts before transplantation |
| 04/30/1998 | WO1998017779A1 NOVEL FabH |
| 04/30/1998 | WO1998017309A1 Induction of rev and tat specific cytotoxic t-cells for prevention and treatment of human immunodeficiency virus (hiv) infection |
| 04/30/1998 | WO1998017305A1 USE OF FasL OR FasL TRANSFECTED CD4+/FasL-/TH1-CELL LINES FOR THE TREATMENT OF TH1/TH2 DISEASES |
| 04/30/1998 | WO1998017301A1 Peptides for inhibiting retroviruses |
| 04/30/1998 | WO1998017300A1 Mucin-mediated immunomodulation |
| 04/30/1998 | WO1998017246A1 Use of complexes for the preparation of compositions for the treatment of sensitive skin, preparation process and hypoallergenic compositions |
| 04/30/1998 | WO1998017116A1 Targeted cytotoxic cells |
| 04/30/1998 | CA2272601A1 Peptides for inhibiting retroviruses |
| 04/30/1998 | CA2271721A1 Mini-e1a genes and gene products |
| 04/30/1998 | CA2269507A1 Targeted cytotoxic cells |
| 04/30/1998 | CA2269349A1 Mucin-mediated immunomodulation |
| 04/30/1998 | CA2269327A1 Use of anti-embryonic hemoglobin antibodies to identify fetal cells |
| 04/30/1998 | CA2269121A1 Production of cartilage tissue using cells isolated from wharton's jelly |
| 04/30/1998 | CA2269034A1 Use of fasl or fasl transfected cd4+/fasl-/th1-cell lines for the treatment of th1/th2 diseases |
| 04/30/1998 | CA2268720A1 Induction of rev and tat specific cytotoxic t-cells for prevention and treatment of human immunodeficiency virus (hiv) infection |
| 04/30/1998 | CA2268271A1 Lentiviral vectors |
| 04/29/1998 | EP0838526A1 Human satellite microchromosomes as vectors for gene therapy |
| 04/29/1998 | EP0838217A2 Cosmetic composition containing neuropeptide Y receptor antagonist |
| 04/29/1998 | EP0838213A1 Use of Krill Enzymes for the Treatment of Dental Plaque |
| 04/29/1998 | EP0837928A1 Recombinant poxvirus - cytomegalovirus compositions and uses |
| 04/29/1998 | EP0837926A2 Method for in vitro proliferation of dentritic cells, composition containing the cells entrapped in a three-dimensional matrix and use for immunization |
| 04/29/1998 | EP0837878A1 Antitumor proteins from rana pipiens oocytes |
| 04/29/1998 | EP0837695A1 Actinomyces pyogenes and actinomyces pyogenes/fusobacterium necrophorum vaccines for immunizing cattle and sheep |
| 04/29/1998 | EP0837692A1 Clostridium difficile toxins as mucosal adjuvants |
| 04/29/1998 | EP0837687A1 Hapten modified tumor cell extract and methods of treating or screening for cancer |
| 04/29/1998 | EP0775008A4 Blood processing systems and methods which restrict in flow of whole blood to increase platelet yields |
| 04/29/1998 | EP0465529B1 Expression of exogenous polynucleotide sequences in a vertebrate |
| 04/29/1998 | CN1179980A Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases |
| 04/29/1998 | CN1179967A Sheep liver extract oral liquor and its producing method |
| 04/29/1998 | CN1179963A Method for preparing animal and plant full natural nutrient solution and its product |
| 04/29/1998 | CN1179957A Spur medicinal powder and preparing method thereof |
| 04/29/1998 | CN1179956A Specific drug for curing rheumatic arthritis and rheumatoid arthritis |
| 04/29/1998 | CN1179950A Non-scar neutral burn ointment |
| 04/28/1998 | US5744584 Antithrombosis agents |
| 04/28/1998 | US5744353 Cytolytic T cell lines which bind to complexes of tumor rejection antigens and HLA-B44 molecules |
| 04/28/1998 | US5744347 Excising; detaching from membrane; collecting cells displaying a particular phenotype capable of giving rise to blood cells |
| 04/28/1998 | US5744327 Methods for producing insulin in response to non-glucose secretagogues |
| 04/28/1998 | US5744316 Used to identify individuals diagnosed with conditions characterized by cellular abnormalities |
| 04/28/1998 | US5744143 Viral vaccines |
| 04/28/1998 | US5744141 Flavivirus recombinant poxvirus immunological composition |
| 04/28/1998 | US5744140 Recombinant poxvirus containing forein dna from encephalitis virus protein m or virus protein e, ns1, and ns2a |
| 04/28/1998 | CA2057926C Chemical products |
| 04/23/1998 | WO1998016626A1 Livestock mucosal competitive exclusion culture to reduce enteropathogenic bacteria |
| 04/23/1998 | WO1998016246A1 Cytokine enhanced immunotherapy for brain tumors |
| 04/23/1998 | WO1998016238A2 Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
| 04/23/1998 | WO1998012225A3 Process for producing a plasma protein-containing medicament |
| 04/23/1998 | WO1998009657A3 Method for recombinant adeno-associated virus-directed gene therapy |
| 04/23/1998 | DE19643093A1 Verwendung von FasL oder mit FasL transfizierten CD4+/FasL-/TH1-Zellinien zur Behandlung von TH1/TH2-Krankheiten, Verfahren zur Herstellung von CD4+/FasL+/TH1-Zellinien und Stoffzusammensetzungen von FasL und einem oder mehren Cytokinen sowie dessen Verwendung zur Behandlung von TH1/TH2-Krankheiten Use of FasL or FasL transfected CD4 + / FasL / TH1 cell lines for the treatment of Th1 / Th2 diseases, processes for the production of CD4 + / FasL + / TH1-cell lines and compositions of FasL and to one or more cytokines, as well as its use for the treatment of Th1 / Th2 diseases |
| 04/23/1998 | CA2267977A1 Cytokine enhanced immunotherapy for brain tumors |
| 04/23/1998 | CA2267233A1 Livestock mucosal competitive exclusion culture to reduce enteropathogenic bacteria |
| 04/22/1998 | EP0837130A2 M protein analogue from Streptococcus pneumoniae |
| 04/22/1998 | EP0837127A2 Hereditary multiple exostose gene, Ext2 |
| 04/22/1998 | EP0836648A1 Recombinant mva virus, and the use thereof |
| 04/22/1998 | EP0836647A2 Antiviral proteins, dna coding sequences therefor, and uses thereof |
| 04/22/1998 | EP0836643A1 Immunoprotective barrier for transplantation of cells |
| 04/22/1998 | EP0836487A1 Device and method for concentrating plasma |
| 04/22/1998 | EP0836484A1 In vitro packaging of adeno-associated virus dna |
| 04/22/1998 | EP0836478A1 Terpene-based pharmaceutical product |